The World Health Organization defines a rare disease as having a prevalence of 65 or less per 100,000 individuals. It recognizes some 5,500 rare diseases, the majority being of genetic origin and often life-threatening. Medical research has yielded significant drug development for the treatment of rare diseases, increasing life expectancy and improving quality of life. However, […]
Roughly a third (34 per cent) of employers in the U.S. are providing coverage for glucagon-like peptide-1 medications for both diabetes care and weight-loss management in 2024, up from 26 per cent in 2023, according to a new survey by the International Foundation of Employee Benefit Plans. However, the survey, which polled more than 270 U.S. employers, found more […]
An article detailing a stark increase in the use of obesity medications among Canadian employer-sponsored benefits plan members was the most-read article on BenefitsCanada.com this week. Here are the top five human resources, benefits, pension and investment stories of the past week: 1. Claims for obesity drugs increased 42% in 2023, 92% since 2020: report 2. How […]
The Public Service Alliance of Canada recently filed a policy grievance against the Treasury Board for its management of the transfer of the Public Service Health Care Plan to Canada Life Assurance Co., which has impacted tens of thousands of federal public service workers covered under the plan. In 2023, the federal government implemented two […]
U.S. employers say they’re expecting their total health benefits plan costs to rise by an average of 5.4 per cent per employee in 2024, according to a new survey by Mercer. The survey, which polled more than 1,900 employers, found the projected increase comes after more than a decade of annual cost increases typically averaging […]
U.S. employers are expecting health benefits costs to increase by an average of 8.5 per cent to more than $15,000 per employee in 2024, according to a new survey by Aon. The survey, which polled 800 U.S. employers, found the projected increase is nearly double the budgeted amount that employers experienced from 2022 to 2023 (4.5 per cent). […]
An announcement regarding long-awaited amendments to the Patented Medicines Review Board regulations was the most-read story on BenefitsCanada.com over the last week. Here are the five most popular news stories of the week: 1. PMPRB drug pricing regulations officially coming into effect this July 2. Key stakeholders highlighting value of private payer health care amid plans for […]
With two of Ontario’s government parties promising to develop portable benefits plans, it’s important to remember that plan sponsors need the freedom to design and price their benefits packages, as well as stability in terms of government processes, says one expert. “Plan sponsors are already delivering programs to a large proportion of the workforce and […]
About three-quarters (78 per cent) of U.S. employers said they’re more focused on the quality of health care over cost management when making decisions about their benefits plan amid the current war for talent acquisition and retention, according to a new survey by Artemis Health Inc. The survey, which polled more than 300 U.S. human […]
The shift to hybrid and remote work models during the ongoing coronavirus pandemic is one of several issues impacting pension plan and group benefits administrators in 2022, said Michael Wolpert, a pensions and benefits lawyer at Fasken Martineau DuMoulin LLP, during a webinar on Jan. 13 hosted by the Canadian Pension & Benefits Institute. Specifically, […]